Say Goodbye to Daily Eye Drops with This New Glaucoma Treatment
Pioneering Glaucoma Care at Anaheim Eye Institute with Voyager™ DSLT
At Anaheim Eye Institute, we’re proud to be one of the first practices in Orange County to offer Voyager™ DSLT (Direct Selective Laser Trabeculoplasty)—an innovative, non-contact laser treatment that’s redefining how we manage glaucoma.
Voyager™ DSLT uses cutting-edge laser technology to deliver 120 precise pulses through the limbus, directly targeting the trabecular meshwork to enhance fluid outflow and lower intraocular pressure (IOP)—all without touching the eye.
Leading the Way in First-Line Glaucoma Treatment
Backed by the groundbreaking LiGHT study, Selective Laser Trabeculoplasty (SLT) has emerged as a proven first-line option for treating open-angle glaucoma (OAG) and ocular hypertension (OHT).
With Voyager™ DSLT, Anaheim Eye Institute delivers:
- Clinically proven IOP reduction with a superior safety profile
- Efficient, non-invasive treatment that fits seamlessly into daily practice
- Enhanced comfort for patients with no need for contact or anesthesia
- Innovation in action—bringing tomorrow’s technology to Orange County today
Clinically Backed IOP Reduction with a Strong Safety Record
Direct Selective Laser Trabeculoplasty (DSLT) for Open-Angle Glaucoma (OAG) and Ocular Hypertension (OHT) has demonstrated safety and efficacy in the GLAUrious randomized controlled trial.
